U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06976606) titled 'A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM' on March 28, 2024.
Brief Summary: An observational study to assess real-world patient characteristics and clinical course of disease in participants with PKP2-ACM.
Study Start Date: Jan. 23, 2024
Study Type: OBSERVATIONAL
Condition:
Arrhythmogenic Cardiomyopathy
PKP2-ACM
PKP2-ARVC
Recruitment Status: RECRUITING
Sponsor: Lexeo Therapeutics
Disclaimer: Curated by HT Syndication....